---
title: "Chase Sun Pharmaceuticals issued a profit warning, expecting a net profit of 48 million to 62 million yuan for the fiscal year 2024, a year-on-year decrease of 90.53% to 87.76%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/225557584.md"
description: "Chase Sun Pharmaceuticals released its performance forecast for 2024, expecting a net profit of 48 million to 62 million yuan, a year-on-year decrease of 90.53%-87.76%. The net profit after deducting non-recurring gains and losses is expected to be 20 million to 30 million yuan, a year-on-year decrease of 94.67%-92.01%"
datetime: "2025-01-20T12:54:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/225557584.md)
  - [en](https://longbridge.com/en/news/225557584.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/225557584.md)
generator: "portal-rs"
---

# Chase Sun Pharmaceuticals issued a profit warning, expecting a net profit of 48 million to 62 million yuan for the fiscal year 2024, a year-on-year decrease of 90.53% to 87.76%

According to the Zhitong Finance APP, Chase Sun (300026.SZ) released its performance forecast for the year 2024. The company expects a net profit attributable to shareholders of the listed company for 2024 to be between 48 million and 62 million yuan, a year-on-year decrease of 90.53% to 87.76%; the net profit after deducting non-recurring gains and losses is expected to be between 20 million and 30 million yuan, a year-on-year decrease of 94.67% to 92.01%

### Related Stocks

- [300026.CN](https://longbridge.com/en/quote/300026.CN.md)

## Related News & Research

- [Livzon Pharma buys 3.5% Xinbeijiang Pharma stake for RMB 106.7 million](https://longbridge.com/en/news/296601614.md)
- [TECHNICALS-CBOT wheat may retest support at $6.60-3/4](https://longbridge.com/en/news/296316121.md)
- [13:49 ETVascarta Outlines Proposed Mechanistic Link Between VAS-101's (Vasceptor®) Vascular and Red Blood Cell Effects in Sickle Cell Disease](https://longbridge.com/en/news/296524035.md)
- [REG - RNS - Final Announcement Released](https://longbridge.com/en/news/296385433.md)
- [REG - Odyssean Inv. Trust - Issue of Equity](https://longbridge.com/en/news/296372102.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**